MSB 3.42% $1.21 mesoblast limited

Agreed patience is required but still need to be vigilant. Pig...

  1. 85 Posts.
    Agreed patience is required but still need to be vigilant. Pig headed stubborness can be rewarded will big capital loss.

    Suggest holders have a look at Pharmaxis (PXS). Aussie Biotech just missed primary endpoint on phase 3 trial.

    One of the posters thanked what he calls the "blackhats" or pesimists on HC for helping him avoid a substantial capital loss.

    Of course, PXS is no MSB, PXS it had all its eggs in one basket and this egg turned out to be rotten (apparently?)but think the posters point is worth consideration.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.